Aker Christopher Ray

Sr. VP & General Counsel at Regulus Therapeutics Inc.

Sold, on record
$86k
Dollars the filings state
Form 4 sales
15
Latest Jan 14, 2025
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Regulus Therapeutics Inc.Plan not stated
    Feb 18, 2020 2020

    Sold 888 shares at $0.83 ($737)

    Aker Christopher Ray, Sr. VP & General Counsel

    Sold 3% of holdings ($24k position)28,419 shares left0.4x usual sizeFiling

  2. 2 Form 4 sale Regulus Therapeutics Inc.Plan not stated
    May 15, 2020 +87 days

    Sold 909 shares at $0.63 ($573)

    Aker Christopher Ray, Sr. VP & General Counsel

    Sold 3.2% of holdings ($18k position)27,510 shares left0.4x usual sizeFiling

  3. 3 Form 4 sale Regulus Therapeutics Inc.Plan not stated
    Aug 14, 2020 +91 days

    Sold 872 shares at $0.61 ($532)

    Aker Christopher Ray, Sr. VP & General Counsel

    Sold 3.2% of holdings ($17k position)26,638 shares left0.4x usual sizeFiling

  4. 4 Form 4 sale Regulus Therapeutics Inc.Plan not stated
    Nov 16, 2020 +94 days

    Sold 876 shares at $0.52 ($456)

    Aker Christopher Ray, Sr. VP & General Counsel

    Sold 3.3% of holdings ($14k position)25,762 shares left0.6x usual sizeFiling

  5. 5 Form 4 sale Regulus Therapeutics Inc.Plan not stated
    Feb 16, 2021 +92 days

    Sold 828 shares at $1.72 ($1k)

    Aker Christopher Ray, Sr. VP & General Counsel

    Sold 1.9% of holdings ($75k position)42,614 shares left0.9x usual sizeFiling

  6. 6 Form 4 sale Regulus Therapeutics Inc.Plan not stated
    May 17, 2021 +90 days

    Sold 860 shares at $0.89 ($765)

    Aker Christopher Ray, Sr. VP & General Counsel

    Sold 2% of holdings ($38k position)41,754 shares left1x usual sizeFiling

  7. 7 Form 4 sale Regulus Therapeutics Inc.Unusual
    Jan 18, 2024 +976 days

    Sold 5,468 shares at $1.19 ($7k)

    Aker Christopher Ray, Sr. VP & General Counsel

    No 10b5-1 planSold 35.2% of holdings ($18k position)10,056 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale Regulus Therapeutics Inc.Routine
    Jan 14, 2025 +362 days

    Sold 43,635 shares at $1.26 ($55k)

    Aker Christopher Ray, Sr. VP & General Counsel

    10b5-1 planSold 46.8% of holdings ($117k position)49,546 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Aker Christopher Ray
Source
Jan 14, 2025Jan 15, 2025Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale43,635$55k46.8%RoutineSEC
Jan 18, 2024Jan 18, 2024Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale5,468$7k35.2%UnusualSEC
May 17, 2021May 17, 2021Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale860$7652.0%Plan not statedSEC
Feb 16, 2021Feb 17, 2021Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale828$1k1.9%Plan not statedSEC
Nov 16, 2020Nov 18, 2020Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale876$4563.3%Plan not statedSEC
Aug 14, 2020Aug 17, 2020Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale872$5323.2%Plan not statedSEC
May 15, 2020May 18, 2020Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale909$5733.2%Plan not statedSEC
Feb 18, 2020Feb 19, 2020Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale888$7373.0%Plan not statedSEC
Jan 2, 2020Jan 3, 2020Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale2,239$2k7.1%Plan not statedSEC
Nov 14, 2019Nov 15, 2019Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale833$5332.6%Plan not statedSEC
Oct 1, 2019Oct 2, 2019Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale2,346$2k6.8%Plan not statedSEC
Aug 15, 2019Aug 16, 2019Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale899$4942.5%Plan not statedSEC
Jul 1, 2019Jul 2, 2019Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale2,225$3k5.9%Plan not statedSEC
May 15, 2019May 16, 2019Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale6,950$10k10.5%Plan not statedSEC
Apr 1, 2019Apr 3, 2019Regulus Therapeutics Inc.Sr. VP & General CounselForm 4 sale2,710$3k30.1%UnusualSEC